|
|
|
|
| LEADER |
01408cam a2200397 4500 |
| 001 |
PPN11430291X |
| 005 |
20170228105900.0 |
| 010 |
|
|
|a 978-0-8493-9073-9
|b rel.
|
| 010 |
|
|
|a 0-8493-9073-7
|b rel.
|
| 020 |
|
|
|a US
|b 2006051461
|
| 100 |
|
|
|a 20070504d2007 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a US
|
| 105 |
|
|
|a y z 001yy
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Nanoparticulate drug delivery systems
|b Texte imprimé
|f edited by Deepak Thassu,... Michel Deleers,... Yashwant Pathak,...
|
| 210 |
|
|
|a New York
|a London
|c Informa Healthcare
|d cop. 2007
|
| 215 |
|
|
|a 1 vol. (X-352 p.)
|c couv. ill.
|d 24 cm
|
| 225 |
2 |
|
|a Drugs and the pharmaceutical sciences
|v 166
|
| 320 |
|
|
|a Notes bibliogr. Index
|
| 410 |
|
| |
|0 039504492
|t Drugs and the pharmaceutical sciences
|x 0360-2583
|v 166
|
| 606 |
|
|
|3 PPN032772793
|a Médicaments
|x Modes d'administration
|x Dispositifs
|2 rameau
|
| 606 |
|
|
|3 PPN031778526
|a Nanoparticules
|2 rameau
|
| 676 |
|
|
|a 615/.6
|v 22
|
| 680 |
|
|
|a RS199.5
|b .N36 2007
|
| 686 |
|
|
|a W1
|b DR893B v.166 2007
|2 usnlm
|
| 686 |
|
|
|a WB 340
|b N184 2007
|2 usnlm
|
| 702 |
|
1 |
|3 PPN114303525
|a Thassu
|b Deepak
|4 340
|
| 702 |
|
1 |
|3 PPN114303827
|a Deleers
|b Michel
|4 340
|
| 702 |
|
1 |
|3 PPN114304327
|a Pathak
|b Yashwant
|4 340
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20071029
|g AFNOR
|
| 801 |
|
0 |
|b DNLM/DLC
|g AACR2
|
| 801 |
|
1 |
|b DLC
|g AACR2
|
| 930 |
|
|
|5 441092101:323713912
|b 441092101
|a QV 704 NAN
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 510817
|
Nantilus
